BACE1 and Alzheimer disease: The Icelandic mutation [25,26] protects from AD (and from aging-associated cognitive decline, AACD) by increasing the efficiency of the cleavage by BACE1 or BACE1-associated activity at the alternative site (β’) ten amino acids residues downstream from the primary BACE1-cleaving site (β).